Cabotegravir-Rilpivirine Combination Effective For Virologic Suppression In Adults With HIV, Study Finds

August 31, 2023

Infectious Disease Advisor (8/30, Kuhns) reports, “Long-acting antiretroviral therapy (ART) with cabotegravir plus rilpivirine is efficacious for the maintenance of virologic suppression in adults with HIV infection, according to results of a study publis...